Ingeborg M.J.A. Kuper

479 total citations
14 papers, 318 citations indexed

About

Ingeborg M.J.A. Kuper is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Ingeborg M.J.A. Kuper has authored 14 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Economics and Econometrics. Recurrent topics in Ingeborg M.J.A. Kuper's work include Frailty in Older Adults (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Ingeborg M.J.A. Kuper is often cited by papers focused on Frailty in Older Adults (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Ingeborg M.J.A. Kuper collaborates with scholars based in Netherlands, Australia and France. Ingeborg M.J.A. Kuper's co-authors include Linda R. Tulner, Jos P.C.M. van Campen, Cornelis H.W. Koks, Desiderius P.M. Brandjes, Jos H. Beijnen, Bianca M. Buurman, Melvin R. Mac Gillavry, Harm van Tinteren, Marije E. Hamaker and Barbara C. Van Munster and has published in prestigious journals such as The Oncologist, Journal of the American Medical Directors Association and Drugs & Aging.

In The Last Decade

Ingeborg M.J.A. Kuper

13 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingeborg M.J.A. Kuper Netherlands 9 151 115 77 64 39 14 318
Sawsan Kurdi Saudi Arabia 8 226 1.5× 145 1.3× 158 2.1× 90 1.4× 37 0.9× 24 405
Jennifer L. Ellis United States 12 86 0.6× 65 0.6× 55 0.7× 91 1.4× 65 1.7× 39 444
J Küpper-Nybelen Germany 8 56 0.4× 60 0.5× 63 0.8× 59 0.9× 43 1.1× 14 350
Andrea Holcombe United States 7 195 1.3× 92 0.8× 18 0.2× 105 1.6× 73 1.9× 17 386
Omar Shoheiber United States 8 61 0.4× 221 1.9× 152 2.0× 63 1.0× 31 0.8× 10 494
John G. O’Meara United States 9 154 1.0× 140 1.2× 14 0.2× 49 0.8× 19 0.5× 14 380
Candice L. Garwood United States 16 141 0.9× 246 2.1× 53 0.7× 58 0.9× 86 2.2× 44 692
Nicky Richards United Kingdom 7 153 1.0× 188 1.6× 14 0.2× 133 2.1× 73 1.9× 9 491
Maja Skov Paulsen Denmark 11 69 0.5× 97 0.8× 23 0.3× 95 1.5× 50 1.3× 18 481
Robert W. Hoel United States 6 180 1.2× 70 0.6× 17 0.2× 85 1.3× 20 0.5× 8 296

Countries citing papers authored by Ingeborg M.J.A. Kuper

Since Specialization
Citations

This map shows the geographic impact of Ingeborg M.J.A. Kuper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingeborg M.J.A. Kuper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingeborg M.J.A. Kuper more than expected).

Fields of papers citing papers by Ingeborg M.J.A. Kuper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingeborg M.J.A. Kuper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingeborg M.J.A. Kuper. The network helps show where Ingeborg M.J.A. Kuper may publish in the future.

Co-authorship network of co-authors of Ingeborg M.J.A. Kuper

This figure shows the co-authorship network connecting the top 25 collaborators of Ingeborg M.J.A. Kuper. A scholar is included among the top collaborators of Ingeborg M.J.A. Kuper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingeborg M.J.A. Kuper. Ingeborg M.J.A. Kuper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Vanhommerig, Joost W., et al.. (2022). Correlation between the number of patient-reported adverse events, adverse drug events, and quality of life in older patients: an observational study. International Journal of Clinical Pharmacy. 44(6). 1434–1441.
2.
Aarden, Jesse J., Esmee M. Reijnierse, Marike van der Schaaf, et al.. (2021). Longitudinal Changes in Muscle Mass, Muscle Strength, and Physical Performance in Acutely Hospitalized Older Adults. Journal of the American Medical Directors Association. 22(4). 839–845.e1. 24 indexed citations
3.
Melis, René J. F., Janet L. MacNeil Vroomen, Bianca M. Buurman, et al.. (2021). Physical Resilience in Daily Functioning Among Acutely Ill Hospitalized Older Adults: The Hospital-ADL Study. Journal of the American Medical Directors Association. 23(5). 903.e1–903.e12. 12 indexed citations
4.
Aarden, Jesse J., Janet L. MacNeil Vroomen, Lucienne A. Reichardt, et al.. (2020). Factors Associated with Step Numbers in Acutely Hospitalized Older Adults: The Hospital-Activities of Daily Living Study. Journal of the American Medical Directors Association. 22(2). 425–432. 16 indexed citations
5.
Seben, Rosanne van, Lucienne A. Reichardt, Jesse J. Aarden, et al.. (2019). Determinants of Post-acute Care Costs in Acutely Hospitalized Older Adults: The Hospital-ADL Study. Journal of the American Medical Directors Association. 20(10). 1300–1306.e1. 12 indexed citations
6.
Seben, Rosanne van, Lucienne A. Reichardt, Jesse J. Aarden, et al.. (2018). The Course of Geriatric Syndromes in Acutely Hospitalized Older Adults: The Hospital-ADL Study. Journal of the American Medical Directors Association. 20(2). 152–158.e2. 43 indexed citations
7.
Hooft, Lotty, Linda R. Tulner, J.H.M. Tulen, et al.. (2014). Acetaminophen for self-reported sleep problems in an elderly population (ASLEEP): study protocol of a randomized placebo-controlled double-blind trial. Trials. 15(1). 10–10. 4 indexed citations
8.
Corvol, Aline, A Gulsvik, Ingeborg M.J.A. Kuper, et al.. (2013). Use of anticoagulants for atrial fibrillation in older subjects across different countries: Cyprus, France, Netherlands, Norway. European Geriatric Medicine. 5(1). 60–65. 4 indexed citations
9.
Jonker, J.M., et al.. (2012). Colon cancer treatment and adherence to national guidelines: Does age still matter?. Journal of Geriatric Oncology. 3(2). 131–137. 9 indexed citations
10.
Hamaker, Marije E., et al.. (2011). The Value of a Comprehensive Geriatric Assessment for Patient Care in Acutely Hospitalized Older Patients with Cancer. The Oncologist. 16(10). 1403–1412. 46 indexed citations
11.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2010). Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review. Current Drug Safety. 5(3). 223–233. 6 indexed citations
12.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2009). Treatment of hypertension in an elderly outpatient population in the Netherlands. ˜The œAmerican journal of geriatric pharmacotherapy. 7(4). 204–209. 4 indexed citations
13.
Tulner, Linda R., Jos P.C.M. van Campen, Ingeborg M.J.A. Kuper, et al.. (2009). Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation. Drugs & Aging. 27(1). 39–50. 82 indexed citations
14.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Suzanne V. Frankfort, et al.. (2009). Discrepancies in reported drug use in geriatric outpatients: Relevance to adverse events and drug-drug interactions. ˜The œAmerican journal of geriatric pharmacotherapy. 7(2). 93–104. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026